Article
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
3 Mar 2022
Abstract excerpt
Abstract The identification of the Omicron (B.1.1.529.1 or BA.1) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021 1 immediately caused concern owing to the number of alterations in the spike glycoprotein that could lead to antibody evasion. We 2 and others 3–6 recently reported results confirming such a concern. Continuing surveillance of the evolution of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
